UBS Knowledge Center / Retire-In-Place
Before you sign the ALFA, price the open market.
UBS's Aspiring Legacy Financial Advisor (ALFA) is the path of least resistance: stay where you are, name a successor, and get paid to wind down. For some advisors that is the right answer. For many, it is simply the easiest one. The difference is worth real money, and you can only see it by looking first.
What it is
The Aspiring Legacy Financial Advisor, fairly described.
UBS's retire-in-place program. A senior advisor names a successor, transitions the book over a defined period, and receives an award of up to 300% of eligible production in exchange for staying at UBS through the handoff rather than selling the practice on the open market.
There is real value here, and we say so plainly. The program pays a genuine multiple, keeps your clients on a platform they know, and removes the friction of a move. The question is not whether it is worth something. It is whether it is worth more than the alternative you never priced.
of eligible production, paid to stay
A real number. But a gross, conditional, multi-year number, not a check. What you net depends on terms most advisors never benchmark.
Why it pulls
The path of least resistance is a real pull.
We are not here to pretend staying has no merit. It does. Naming the appeal honestly is the only way to weigh it.
- No move and no re-papering. Your clients stay on the platform and with the service team they already know.
- A defined, contractual payout instead of the uncertainty of sourcing and vetting an outside buyer.
- You keep producing and earning while you wind down, on a timeline that looks orderly on paper.
- Succession mechanics are handed to the firm to administer, so the paperwork comes off your plate.
What you actually sign
The multiple is the easy part to see.
The headline number is designed to be visible. What you trade for it is not. Each of these is specific to UBS's ALFA, and each one moves the real value of the deal.
Multi-year lock-in
The award is paid for staying. Signing converts your remaining years into a contract with UBS, which narrows your exit options at precisely the moment firm direction, leadership, or grid economics may be shifting under you.
A bet on UBS's trajectory
ALFA pays out over a window in which you are betting on UBS's platform, support, and stability. The Credit Suisse integration friction and the move to a Highest Producer Grid are live reminders that the firm you sign with may not be the firm you finish with.
Diminished outside value
A practice contractually committed to one firm is worth less to any other. The restrictions inside a retire-in-place agreement can lower what your business would command in an open-market sale you have now closed off.
Fiduciary narrowing
Bound to a single platform for the duration, your ability to place clients in the best available solution is shaped by the contract rather than purely by their interests.
Your successor inherits the constraints
The next-generation advisor steps into the same lock-ins. What looks like a clean handoff can hand your successor a narrower starting position than the one you began with.
Staying can be the right move. But “right” and “easiest” are not the same word, and only one of them is worth signing a multi-year contract over.
An advisor who has quietly benchmarked their practice against the open market signs from a position of knowledge. An advisor who signs first, and looks later, has already given up the one piece of leverage that was theirs to keep.
Before you sign
Five questions worth a real answer.
If you can answer these with confidence, sign with confidence. If any of them gives you pause, that pause is worth a conversation before a signature.
- 01
Have you priced what your practice would sell for on the open market before accepting UBS's number, so you know whether 300% is generous or merely convenient?
- 02
Are you confident UBS's platform, support, and economics will hold up across the full award period, given the Credit Suisse integration and recent grid changes?
- 03
What precisely happens to your award if you decide to leave, if leadership changes direction, or if the firm alters terms during the contract?
- 04
How does the after-tax, paid-over-time value of the ALFA award compare to a lump-sum or equity-bearing alternative elsewhere?
- 05
Does signing serve your clients' long-term interests, or does it bind you to a platform that may not remain their best home?
Price the alternative. Then decide.
A confidential, no-pressure read on what your practice is worth on the open market, and how it compares to the ALFA offer in front of you. You keep the analysis whether you stay or go.